HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Xiaoni Liu Selected Research

cytotropic heterogeneous molecular lipid (CHML)

1/2019High expression of CHML predicts poor prognosis of multiple myeloma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Xiaoni Liu Research Topics

Disease

20Neoplasms (Cancer)
01/2024 - 05/2012
8Hepatocellular Carcinoma (Hepatoma)
01/2024 - 10/2017
6Autoimmune Diseases of the Nervous System
03/2024 - 01/2022
6Type 2 Diabetes Mellitus (MODY)
09/2016 - 11/2011
3Neoplasm Metastasis (Metastasis)
01/2024 - 01/2017
3Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2023 - 01/2023
3Melanoma (Melanoma, Malignant)
10/2021 - 03/2016
3Multiple Myeloma
01/2020 - 01/2019
2Encephalitis (Encephalitis, Rasmussen)
01/2023 - 01/2022
2Leukemia
01/2023 - 01/2020
2Breast Neoplasms (Breast Cancer)
01/2023 - 12/2018
2Central Nervous System Diseases (CNS Diseases)
01/2023 - 01/2023
2Liver Neoplasms (Liver Cancer)
10/2017 - 05/2012
2Cardiovascular Diseases (Cardiovascular Disease)
01/2015 - 02/2012
1Optic Neuritis (Retrobulbar Neuritis)
03/2024
1Dysarthria (Spastic Dysarthria)
12/2023
1Gait Ataxia
12/2023
1Cerebellar Ataxia (Dysmetria)
12/2023
1Carcinogenesis
09/2023
1Glioma (Gliomas)
01/2023
1Pantothenate Kinase-Associated Neurodegeneration (Hallervorden-Spatz Disease)
01/2023
1Hematologic Neoplasms (Hematological Malignancy)
01/2023
1Non-alcoholic Fatty Liver Disease
01/2023
1Peripheral Nervous System Diseases (PNS Diseases)
01/2023
1Inflammation (Inflammations)
01/2023
1Thymoma (Thymic Carcinoma)
01/2023
1Neuroinflammatory Diseases
01/2023
1Seizures (Absence Seizure)
01/2023
1Multiple Sclerosis
01/2023
1Connective Tissue Diseases (Connective Tissue Disease)
06/2022
1Meningitis
01/2022
1Neurodegenerative Diseases (Neurodegenerative Disease)
01/2022
1Parkinson Disease (Parkinson's Disease)
01/2022
1Wounds and Injuries (Trauma)
10/2020
1Fanconi Anemia (Fanconi's Anemia)
11/2019
1Hypoxia (Hypoxemia)
02/2019
1Ischemia
02/2019
1Choroideremia
01/2019
1Anti-N-Methyl-D-Aspartate Receptor Encephalitis
01/2019

Drug/Important Bio-Agent (IBA)

10Proteins (Proteins, Gene)FDA Link
09/2023 - 01/2017
7dapagliflozinIBA
09/2016 - 11/2011
6Glucose (Dextrose)FDA LinkGeneric
01/2014 - 11/2011
4Biomarkers (Surrogate Marker)IBA
12/2023 - 11/2019
4RNA (Ribonucleic Acid)IBA
01/2023 - 01/2020
3MicroRNAs (MicroRNA)IBA
01/2022 - 01/2017
3SodiumIBA
09/2013 - 11/2011
2Immunoglobulin G (IgG)IBA
03/2024 - 01/2023
2Competitive Endogenous RNAIBA
01/2023 - 01/2017
2Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
11/2022 - 01/2019
2AntibodiesIBA
06/2022 - 01/2022
2Nucleic AcidsIBA
01/2022 - 01/2017
2Oxaliplatin (Eloxatin)FDA LinkGeneric
10/2017 - 01/2017
2Sodium-Glucose Transport ProteinsIBA
09/2016 - 08/2013
2Caspase 3 (Caspase-3)IBA
03/2014 - 10/2012
2Sodium-Glucose Transporter 2 InhibitorsIBA
01/2014 - 09/2013
2Death Domain ReceptorsIBA
10/2012 - 09/2012
1AntigensIBA
03/2024
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2024
1SteroidsIBA
12/2023
1Therapeutic UsesIBA
12/2023
1Mevalonic Acid (Mevalonate)IBA
09/2023
1pantothenate kinaseIBA
01/2023
1Cytochrome P-450 CYP2C8IBA
01/2023
1Cytochrome P-450 CYP2C9IBA
01/2023
1N,N- diethyl- 2- (2- (4- (2- fluoroethoxy)phenyl)- 5,7- dimethylpyrazolo(1,5- a)pyrimidin- 3- yl)acetamideIBA
01/2023
1Cytochrome P-450 CYP2C19IBA
01/2023
1frequenin calcium sensor proteins (neuronal calcium sensor 1)IBA
01/2023
1Glial Fibrillary Acidic ProteinIBA
01/2023
1Oligoclonal BandsIBA
01/2023
1AutoantigensIBA
01/2023
1Leucine (L-Leucine)FDA Link
01/2023
1LipidsIBA
01/2023
1Cytochrome P-450 CYP3AIBA
01/2023
1Sorafenib (BAY 43-9006)FDA Link
01/2023
1Paclitaxel (Taxol)FDA LinkGeneric
11/2022
1K-18 conjugate (K18)IBA
11/2022
1AutoantibodiesIBA
01/2022
11- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA
01/2022
1HeterochromatinIBA
10/2021
1Immune Checkpoint InhibitorsIBA
10/2021
1pien tze huangIBA
10/2020
1Streptozocin (Streptozotocin)FDA Link
10/2020
1CateninsIBA
01/2020
1Immunoglobulins (Immunoglobulin)IBA
01/2020
1Ubiquitin-Conjugating EnzymesIBA
11/2019
1Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA
11/2019
1Small Interfering RNA (siRNA)IBA
02/2019
1Messenger RNA (mRNA)IBA
01/2019
1N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA
01/2019
1X-Linked Inhibitor of Apoptosis ProteinIBA
01/2019
1Rituximab (Mabthera)FDA Link
01/2019
1cytotropic heterogeneous molecular lipid (CHML)IBA
01/2019
1Estrogen Receptor Modulators (Antiestrogen)IBA
12/2018

Therapy/Procedure

5Therapeutics
01/2024 - 01/2017
4Immunotherapy
12/2023 - 10/2021
4Chinese Traditional Medicine (Traditional Chinese Medicine)
10/2020 - 05/2012
3Drug Therapy (Chemotherapy)
01/2023 - 01/2019
1Aftercare (After-Treatment)
01/2023
1Hematopoietic Stem Cell Transplantation
01/2020
1Liver Transplantation
02/2019